Kohei Nishikawa Selected Research

silodosin

1/2011

Naftopidil, a selective {alpha}1-adrenoceptor antagonist, suppresses human prostate tumor growth by altering interactions between tumor cells and stroma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Kohei Nishikawa Research Topics

Disease

4	Neoplasms (Cancer) 09/2019 - 09/2006
3	Prostatic Neoplasms (Prostate Cancer) 11/2021 - 09/2006
1	Interstitial Lung Diseases (Interstitial Lung Disease) 05/2022
1	Renal Cell Carcinoma (Grawitz Tumor) 05/2022
1	Sleep Initiation and Maintenance Disorders (Insomnia) 12/2021
1	Myocarditis (Carditis) 11/2020
1	Adenocarcinoma 04/2020
1	Prostatic Hyperplasia (Benign Prostatic Hyperplasia) 09/2006

Drug/Important Bio-Agent (IBA)

2	AndrogensIBA 09/2019 - 01/2011
1	STAT3 Transcription Factor (Signal Transducer and Activator of Transcription 3)IBA 05/2022
1	TOR Serine-Threonine KinasesIBA 05/2022
1	Polymethyl Methacrylate (Sol)IBA 12/2021
1	Androgen Antagonists (Antiandrogens)IBA 11/2021
1	Immune Checkpoint InhibitorsIBA 11/2020
1	Cisplatin (Platino)FDA LinkGeneric 04/2020
1	Gemcitabine FDA Link 04/2020
1	Prostate-Specific Antigen (Semenogelase)IBA 09/2019
1	Androgen Receptors (Androgen Receptor)IBA 09/2019
1	Calmodulin-Binding Proteins (Caldesmon)IBA 01/2019
1	DesminIBA 01/2019
1	silodosin FDA Link 01/2011
1	Tamsulosin (Flomax)FDA LinkGeneric 01/2011
1	Adrenergic Receptors (Adrenergic Receptor)IBA 01/2011
1	naftopidilIBA 01/2011

Therapy/Procedure

3	Therapeutics 12/2021 - 09/2006
2	Castration 11/2021 - 09/2019
1	Drug Therapy (Chemotherapy) 04/2020
1	Prostatectomy (Retropubic Prostatectomy) 09/2006